¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neonatal thrombocytopenia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® neonatal intensive care center ÇÑ±Û ½Å»ý¾Æ ÁýÁßÄ¡·á½Ç
¼³¸í   
  ¹Ì¼÷¾Æ³ª °¡»ç »óÅÂÀÇ Ãâ»ê¾Æ¸¦ ÁýÁßÀûÀ¸·Î º¸»ìÇǰí Ä¡·áÇϴ ±â°ü.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal thrombocytopenia
    ½Å»ý¾ÆÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æµ¿Á¾¸é¿ªÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • amegakaryocytic thrombocytopenia
    ¹«°Å´ëÇÙ¼¼Æ÷Ç÷¼ÒÆÇ°¨¼Ò(Áõ)
  • essential thrombocytopenia
    º»ÅÂÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • immune thrombocytopenia
    ¸é¿ª¼ºÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • early neonatal mortality rate
    Á¶±â½Å»ý¾Æ»ç¸Á·ü
  • neonatal
    ½Å»ý¾Æ-
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • neonatal asphyxia
    ½Å»ý¾ÆÁú½Ä
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal blennorrhea
    °«³­¾Ö°í¸§´«¹°, ½Å»ý¾Æ³ó·ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • neonatal death rate
    ½Å»ý¾Æ»ç¸Á·ü
  • neonatal diarrhea
    ½Å»ý¾Æ¼³»ç
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • thrombocytopenia
    ÀúÇ÷¼ÒÆÇÁõ
  • neonatal intensive care center
    ½Å»ý¾ÆÁýÁßÄ¡·á½Ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • neonatal infection
    °«³­¾Ö°¨¿°, ½Å»ý¾Æ°¨¿°
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á·ü
  • neonatal period
    ½Å»ý¾Æ±â
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal thrombocytopenia
    ½Å»ý¾ÆÀúÇ÷¼ÒÆÇÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æµ¿Á¾¸é¿ªÀúÇ÷¼ÒÆÇÁõ
  • amegakaryocytic thrombocytopenia
    ¹«°Å´ëÇÙ¼¼Æ÷ÀúÇ÷¼ÒÆÇÁõ
  • immune thrombocytopenia
    ¸é¿ªÀúÇ÷¼ÒÆÇÁõ
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÀúÇ÷¼ÒÆÇÁõ
  • thrombocytopenia
    ÀúÇ÷¼ÒÆÇÁõ
  • neonatal anemia
    ½Å»ý¾ÆºóÇ÷
  • neonatal asphyxia
    ½Å»ý¾ÆÁú½Ä
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal blennorrhea
    °«³­¾Ö°í¸§´«¹°
  • neonatal intensive care center
    ½Å»ý¾ÆÁýÁßÄ¡·á½Ç
  • neonatal death
    ½Å»ý¾Æ»ç¸Á, ¿µ¾Æ»ç
  • neonatal diarrhea
    ½Å»ý¾Æ¼³»ç
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amegakaryocytic thrombocytopenia
    ¹«°ÅÇÙ±¸¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(ÙíËÝú·Ï¹àõúìá³÷ùÊõá´ñø).
  • amegakaryocytic thrombocytopenia
    ¹«°ÅÇÙ±¸¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(ËÎ˧̴˴ËÛÌ´ËÛ̬˧ËÛÌ¡).
  • hemangioma thrombocytopenia syndrome
    Ç÷°üÁ¾Ç÷¼ÒÆÇ°¨¼ÒÁõÈıº.
  • hemorrhagic diathesis,thrombocytopenia
    Ç÷¼ÒÆÇ°¨¼ÒÁõ(¡­Êõá´ñø)
  • immune thrombocytopenia
    ¸é¿ªÇ÷¼ÒÆÇ°áÇÌÁõ
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼ÒÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alloimmune neonatal thrombocytopenia=ANN
    µ¿Á¾¸é¿ª¼º½Å»ý¾ÆÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • neonatal alloimmune thrombocytopenia=NAIT
    ½Å»ý¾Æµ¿Á¾¸é¿ªÇ÷¼ÒÆÇ °áÇÌÁõ
  • amegakaryocytic thrombocytopenia
    ¹«°ÅÇÙ±¸¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(ÙíËÝú·Ï¹àõúìá³÷ùÊõá´ñø).
  • amegakaryocytic thrombocytopenia
    ¹«°ÅÇÙ±¸¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(ËÎ˧̴˴ËÛÌ´ËÛ̬˧ËÛÌ¡).
  • autoimmune thrombocytopenia=AITP
    ÀÚ°¡¸é¿ª¼ºÇ÷¼ÒÆÇ °¨¼ÒÁõ
  • congenital immunologic thrombocytopenia
    ¼±Ãµ¼º ¸é¿ª¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(¡­Øóæ¹ àõúìá³÷ùÊõá´ñø).
  • hemangioma thrombocytopenia syndrome
    Ç÷°üÁ¾Ç÷¼ÒÆÇ°¨¼ÒÁõÈıº.
  • hemorrhagic diathesis,thrombocytopenia
    Ç÷¼ÒÆÇ°¨¼ÒÁõ(¡­Êõá´ñø)
  • immune thrombocytopenia
    ¸é¿ªÇ÷¼ÒÆÇ°áÇÌÁõ
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • secondary thrombocytopenia
    ÀÌÂ÷¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ.
  • secondary thrombocytopenia
    ÀÌÂ÷¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(úìáÈ÷ùÊõá´ñø)
  • thrombocytopenia
    Ç÷¼ÒÆÇ°¨¼ÒÁõ(úìá³÷úÊõá´ñø), Ç÷Àü±¸(úìîûϹ)°¨¼ÒÁõ
  • thrombocytopenia
    Ç÷¼ÒÆÇ°¨¼ÒÁõ
  • thrombocytopenia
    Ç÷¼ÒÆÇ°¨¼ÒÁõ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Neonatal period
    ½Å»ý¾Æ±â
    [¿¾ ¿ë¾î] ½Å»ý¾Æ±â
  • Neonatal line
    ù¼ºÀå¼±
    [¿¾ ¿ë¾î] ½Å»ý¼±
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal
    ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
  • neonatal atelectasis
    ½Å»ý¾Æ¹«±âÆó
  • neonatal jaundice
    ½Å»ý¾ÆÈ²´Þ
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á(·ü)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NAT N-acetyltransferase; natal; neonatal alloimmune thrombocytopenia; no action taken; nonaccidental tra...
TAR Thrombocytopenia-Absent Radius
DIT deferoxamine infusion test; diet-induced thermogenesis; diiodotyrosine; drug-induced thrombocytopeni...
HAT Halsted Aphasia Test; head, arm, trunk; heparin-associated thrombocytopenia; heterophil antibody tit...
HATT heparin-associated thrombocytopenia and thrombosis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NAIT Neonatal alloimmune thrombocytopenia
NAITP Neonatal alloimmune thrombocytopenia
AITP Autoimmune thrombocytopenia
HAT Heparin associated thrombocytopenia
HIT Heparin induced thrombocytopenia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æ µ¿Á¾ ¸é¿ª Ç÷¼ÒÆÇ °áÇÌÁõ
  • idiopathic thrombocytopenia
    Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄ Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • primary thrombocytopenia
    ¿ø¹ß¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • secondary thrombocytopenia
    ÀÌÂ÷¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • thrombocytopenia
    Ç÷¼ÒÆÇ °¨¼ÒÁõ, Ç÷Àü±¸ °¨¼ÒÁõ
    Ç÷¾× ³» Ç÷¼ÒÆÇÀÇ ¼ýÀÚ°¡ °¨¼ÒÇÏ´Â °Í.
  • neonatal
    ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
    µ¿ÀǾî=neonate. Ãâ»ý ÈÄ Ã³À½ 4ÁÖ¸¦ ¾ð±Þ.
  • neonatal anesthesia
    ½Å»ý¾Æ ¸¶Ãë
  • neonatal asphyxia
    ½Å»ý¾Æ °¡»ç, ½Å»ý¾Æ Áú½Ä
  • neonatal blennorrhea
    ½Å»ý¾Æ ¾È ³ó·ç
  • neonatal calf diarrhea corona virus
    ½Å»ý¾Æ ¼³»ç Äڷγª ¹ÙÀÌ·¯½º
  • neonatal death
    ½Å»ý¾Æ »ç¸Á
  • neonatal diarrhea
    ½Å»ý¾Æ ¼³»ç
  • neonatal eruptive hemangiomatosis
    ¹ßÁø¼º ½Å»ý¾Æ Ç÷°üÁ¾Áõ
  • neonatal hepatitis
    ½Å»ý¾Æ °£¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
isoimmune neonatal thrombocytopenia Immune thrombocytopenia resulting from maternal-foetal platelet incompatibility.
(05 Mar 2000)
autoimmune thrombocytopenia purpura <haematology> A rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.
The platelet count becomes exceedingly low and spontaneous bleeding from the gums, gastrointestinal tract and nose can be seen. Physical examination may demonstrate enlargement of the spleen. A typical rash occurs to do microscopic haemorrhage of small blood vessels in the skin.
Platelet counts under 10,000 can lead to spontaneous haemorrhage into the brain causing death. Treatment with corticosteroids is generally effective. Surgical removal of the spleen (splenectomy) is reserved for some patients.
Anti-platelet antibodies are detectable in some cases. It may present in either an acute or a chronic form.
Acronym: ITP
(20 Sep 2002)
canine infectious cyclic thrombocytopenia An infection of dogs with the rickettsia Ehrlichia platys characterised by recurrent cyclic thrombocytopenia.
(05 Mar 2000)
radial aplasia-thrombocytopenia syndrome <syndrome> Aplasia (absence) of the radius (the long bone on the thumb-side of the forearm) and thrombocytopenia (low blood platelets) are key features characterizing this syndrome. There is phocomelia (flipper-limb) with the thumbs always present. The fibula (the smaller bone in the lower leg) is often absent. The risk of bleeding from too few platelets is high in early infancy but lessens with age. The condition is inherited in an autosomal recessive trait with one gene (on a non-sex chromosome) coming from each parent to the child affected with the disease. Alternative names include thrombocytopenia-absent radius syndrome, tar syndrome, and tetraphocomelia-thrombocytopenia syndrome.
(12 Dec 1998)
haemangioma-thrombocytopenia syndrome <syndrome> Thrombocytopenia caused by sequestration and destruction of platelets in a large cavernous haemangioma, usually seen in infants, rare in adults
(12 Dec 1998)
syndrome, radial aplasia-thrombocytopenia See syndrome, tar.
(12 Dec 1998)
syndrome, tetraphocomelia-thrombocytopenia See syndrome, tar.
(12 Dec 1998)
syndrome, thrombocytopenia-absent radius See Syndrome, TAR.
(12 Dec 1998)
idiopathic thrombocytopenia purpura <haematology> A rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.
The platelet count becomes exceedingly low and spontaneous bleeding from the gums, gastrointestinal tract and nose can be seen. Physical examination may demonstrate enlargement of the spleen. A typical rash occurs to do microscopic haemorrhage of small blood vessels in the skin.
Platelet counts under 10,000 can lead to spontaneous haemorrhage into the brain causing death. Treatment with corticosteroids is generally effective. Surgical removal of the spleen (splenectomy) is reserved for some patients.
Anti-platelet antibodies are detectable in some cases. It may present in either an acute or a chronic form.
Acronym: ITP
(20 Sep 2002)
immune thrombocytopenia Thrombocytopenia associated with antiplatelet antibodies.
See: isoimmune neonatal thrombocytopenia, autoimmune neonatal thrombocytopenia.
(05 Mar 2000)
tetraphocomelia-thrombocytopenia syndrome <syndrome> Tar stands for thrombocytopenia (low blood platelets) and aplasia (absence) of the radius (the long bone on the thumb-side of the forearm), features characterizing this syndrome. There is phocomelia (flipper-limb) with the thumbs always present. The fibula (the smaller bone in the lower leg) is often absent. The risk of bleeding from too few platelets is high in early infancy but lessens with age. The condition is inherited in an autosomal recessive trait with one gene (on a non-sex chromosome) coming from each parent to the tar child. Alternative names include thrombocytopenia-absent radius syndrome, radial aplasia-thrombocytopenia syndrome, and tetraphocomelia-thrombocytopenia syndrome.
(12 Dec 1998)
thrombocytopenia <haematology> A decrease in the number of platelets in the blood, resulting in the potential for increased bleeding and decreased ability for clotting.
Origin: Gr. Penia = poverty
(18 Nov 1997)
thrombocytopenia-absent radius syndrome <syndrome> Tar stands for thrombocytopenia (low blood platelets) and aplasia (absence) of the radius (the long bone on the thumb-side of the forearm), features characterizing this syndrome. There is phocomelia (flipper-limb) with the thumbs always present. The fibula (the smaller bone in the lower leg) is often absent. The risk of bleeding from too few platelets is high in early infancy but lessens with age. The condition is inherited in an autosomal recessive trait with one gene (on a non-sex chromosome) coming from each parent to the tar child. Alternative names include thrombocytopenia-absent radius syndrome, radial aplasia-thrombocytopenia syndrome, and tetraphocomelia-thrombocytopenia syndrome.
(12 Dec 1998)
thrombocytopenia purpura <haematology> In severe thrombocytopenia, bleeding into skin leads to small petechial haemorrhages.
Primary thrombocytopenia purpura is of unknown cause but results from an autoimmune mechanism that causes platelet destruction.
Secondary thrombocytopenic purpura may result from drug-induced type II hypersensitivity in which platelets coated with antibody to the drug (which is acting as a hapten) are destroyed in a complement mediated reaction. It can also follow a viral upper respiratory infection and may be seen in association with lupus.
(15 Oct 1997)
essential thrombocytopenia A primary form of thrombocytopenia, in contrast to secondary forms that are associated with metastatic neoplasms, tuberculosis, and leukaemia involving the bone marrow, or with direct suppression of bone marrow by the use of chemical agents, or with other conditions.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neonatal
    ½Å»ý¾ÆÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á